diazoxide has been researched along with Genetic Predisposition in 3 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kandasamy, B | 1 |
| Shyng, SL | 1 |
| Roy, K | 1 |
| Satapathy, AK | 1 |
| Houhton, JAL | 1 |
| Flanagan, SE | 1 |
| Radha, V | 1 |
| Mohan, V | 1 |
| Sharma, R | 1 |
| Jain, V | 1 |
| Dekel, B | 1 |
| Lubin, D | 1 |
| Modan-Moses, D | 1 |
| Quint, J | 1 |
| Glaser, B | 1 |
| Meyerovitch, J | 1 |
3 other studies available for diazoxide and Genetic Predisposition
| Article | Year |
|---|---|
Methods for Characterizing Disease-Associated ATP-Sensitive Potassium Channel Mutations.
Topics: Animals; Blotting, Western; Chlorocebus aethiops; Congenital Hyperinsulinism; COS Cells; Diabetes Me | 2018 |
Congenital Hyperinsulinemic Hypoglycemia and Hyperammonemia due to Pathogenic Variants in GLUD1.
Topics: Congenital Hyperinsulinism; Diazoxide; Female; Genetic Predisposition to Disease; Glutamate Dehydrog | 2019 |
Compound heterozygosity for the common sulfonylurea receptor mutations can cause mild diazoxide-sensitive hyperinsulinism.
Topics: ATP-Binding Cassette Transporters; Diazoxide; Electrophoresis, Gel, Two-Dimensional; Genetic Predisp | 2002 |